Article Information
PubMed
Published By
History
- Received June 28, 2019
- Accepted September 10, 2019
- Published online May 1, 2020.
Article Versions
- Previous version (February 18, 2020 - 16:30).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2020, The Authors This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)
Author Information
- Marc De Meulemeester, MD, PhD1,*,
- Elsa Mateus, PhD2,
- Hilda Wieberneit-Tolman3,
- Neil Betteridge, BA Hons, MPhil4,
- Lucy Ireland, MA5,
- Gudula Petersen, PhD6,
- Nina Jeanette Maske, BSc7,
- Tim L Jansen, MD, PhD8 and
- Fernando Perez-Ruiz, MD, PhD9
- 1 GP Private Practice, Cabinet Médical Demeulemeester, Gozée, Belgium
- 2 President of the Board of Portuguese League Against Rheumatic Diseases, Liga Portuguesa Contra as Doenças Reumáticas, Lisboa, Portugal
- 3 Executive Director of PijnPlatform Nederland, Pijn Platform Nederland, Leiden, The Netherlands
- 4 Director, Neil Betteridge Associates, London, UK
- 5 Health Partner, Hall & Partners, London, UK
- 6 Director Governmental Affairs & Patient Centricity, Grünenthal GmbH, Aachen, Germany
- 7 Senior Manager Market Research & Insights, Department Analytics & Insights, Grünenthal GmbH, Aachen, Germany
- 8 Medical Leader, Department of Rheumatology, Expert Centre Complex Gout, VieCuri Medical Centre, Venlo, The Netherlands
- 9 Associate Professor, Department of Medicine, Medicine and Nursery School, University of the Basque Country, Cruces, Spain
- ↵
*For correspondence:
Marc De Meulemeester, demeu{at}brutele.be